Basics PMV Pharmaceuticals, Inc. IPO Date: September 25, 2020 Sector: Healthcare Industry: Biotech Market Cap: $45.56M Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 3.36% Avg Daily Range (30 D): $0.02 | 2.30% Avg Daily Range (90 D): $0.03 | 2.49% Institutional Daily Volume Avg Daily Volume: .4M Avg Daily Volume (30 D): .22M Avg Daily Volume (90 D): .14M Trade Size Avg Trade Size (Sh.): 96 Avg Trade Size (Sh.) (30 D): 443 Avg Trade Size (Sh.) (90 D): 278 Institutional Trades Total Inst.Trades: 874 Avg Inst. Trade: $2.32M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $.68M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.22M Avg Closing Trade (30 D): $6.87M Avg Closing Trade (90 D): $6.87M Avg Closing Volume: 147.98K     News Jun 3, 2024 @ 1:55 PM Here's Why PMV Pharmaceuticals (PMVP) Could be Gre... Source: Zacks Equity Research May 29, 2024 @ 11:00 AM Foundation Medicine and PMV Pharma Announce Collab... Source: PMV Pharmaceuticals, Inc. May 28, 2024 @ 1:47 PM Here's Why You Should Buy Acrivon Therapeutics (AC... Source: Zacks Equity Research Mar 18, 2024 @ 8:01 PM PMV Pharmaceuticals PYNNACLE Phase I Data of Rezat... Source: PMV Pharmaceuticals, Inc. Feb 29, 2024 @ 9:01 PM PMV Pharmaceuticals Reports Full Year 2023 Financi... Source: PMV Pharmaceuticals, Inc. Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.34 $-.37 Diluted EPS $-.34 $-.37 Revenue $ $ 1.94M $ 2.62M Gross Profit $ $ $ Net Income / Loss $ $ -17.44M $ -19.23M Operating Income / Loss $ $ -21.56M $ -21.89M Cost of Revenue $ $ $ Net Cash Flow $ $ 10.46M $ .28M PE Ratio